Astec Lifesciences Ltd Stock Analysis

BSE: 533138 | NSE: ASTEC | Pesticides & Agrochemicals | Small Cap

BSE Share Price 23-Sep-2022 18:01
1883.25 -11.05 (-0.58%)

DeciZen - Make an Informed Decision on Astec Lifesciences

Overall Rating

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Astec Lifesciences Price Chart

P/E Ratio (CD) :
41.70
Market Cap :
3,692 Cr.
52-wk low :
1,113
52-wk high :
2,178.9
Bole Toh?

1. Is Astec Lifesciences Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Astec Lifesciences Ltd is a below average quality company.

2. Is Astec Lifesciences Ltd undervalued or overvalued?

The key valuation ratios of Astec Lifesciences Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Astec Lifesciences Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Astec Lifesciences Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Astec Lifesciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Astec Lifesciences Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
ROCE % 6.6%9.2%17.2%5.7%10.8%9.1%12.8%14.5%15.7%15.3%-
Value Creation Index -0.5-0.40.2-0.6-0.2-0.4-0.10.00.10.1-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 175207267247299368431523555677732
YoY Gr. Rt. %-18.4%29%-7.5%20.9%23.1%17.2%21.3%6.2%21.9%-
Adj EPS 3.55.814.12.39.79.217.722.43242.545
YoY Gr. Rt. %-65.1%144.5%-83.8%324%-5.2%91.9%26.5%43.3%32.9%-
BVPS (₹) 58.461.369.660.370.486.4103.2125.7157.6202.2207.9
Adj Net Profit 6.310.727.54.518.91834.643.762.783.488
Cash Flow from Ops. 16.414.67.5-12.519.264.715.3168-8.223.6-
Debt/CF from Ops. 4.45.712.5-10.16.61.911.50.6-22.911.8-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 16.2%17.8%16.2%21.9%
Adj EPS 32%34.4%34%32.9%
BVPS 14.823.525.128.3
Share Price 50.5% 25.7% 66.4% 43.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22TTM
Return on Equity % 6.29.822.13.514.811.718.619.522.623.622
Op. Profit Mgn % 16.218.220.713.92118.717.816.320.122.721.2
Net Profit Mgn % 3.65.210.31.86.44.988.411.312.312.1
Debt to Equity 0.70.70.71.10.90.70.90.40.60.7-
Working Cap Days 2042192233042482332232172292360
Cash Conv. Cycle 911138410591929560531020

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 22.00%

Sales growth is growing at healthy rate in last 3 years 16.23%

Net Profit is growing at healthy rate in last 3 years 34.03%

Debt to equity has declined versus last 3 years average to 0.71

Sales growth is good in last 4 quarters at 29.26%

No data to display

Latest Financials - Astec Lifesciences Ltd.

Standalone Consolidated
TTM EPS (₹) 45 45
TTM Sales (₹ Cr.) 732 732
BVPS (₹.) 207.7 207.9
Reserves (₹ Cr.) 387 388
P/BV 9.07 9.03
PE 41.84 41.70
From the Market
52 Week Low / High (₹) 1113.00 / 2178.85
All Time Low / High (₹) 14.45 / 2178.85
Market Cap (₹ Cr.) 3,692
Equity (₹ Cr.) 19.6
Face Value (₹) 10
Industry PE 33.7

Management X-Ray of Astec Lifesciences :

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Astec Lifesciences

Adj EPS (Rs.)
Sales (Cr.)
ROE (%)
ROCE (%)

News

About Astec Lifesciences Ltd

Astec is proud of its rich experience of over two decades in the chemical industry. The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. Astec prides itself in being responsive, reliable and quick to implement projects. A strong R&D focus has enabled the company to introduce a number of unique products. As the operations are highly integrated both vertically and horizontally, Astec has a very efficient, low cost structure in the market place.

Strong emphasis on quality, backed by a highly competent technical team, has enabled Astec to establish a successful track record in nurturing stable and long term relationships with highly reputed companies in USA, Japan and Europe. Above all, utmost respect for confidentiality, reliability, integrity and commitment in all its business relationships make Astec an ideal outsourcing partner. Astec Chemicals operates an ISO 9001:2000 certified Quality Assurance system.

The company has technologically sophisticated facilities for process development work and has demonstrated its ability to synthesize complex molecules rapidly. All its laboratories are equipped to carry out reactions from gm-scale to kilo-scale {up to 20 litres}.

Scale up to multikilo level is undertaken at its versatile 50-500 lts capacity pilot plant. Setting up a feasibility study through to laboratory development, pilot scale-up and full scale production are governed by the highest safety, quality and environmental standards.

Astec has multipurpose production facilities at two locations.

• Dombivli (50 km from Mumbai) • Mahad - two plants ( 180 kms from Mumbai)

They are multi-purpose plants based on 3,000-20,000 litres glasslined and stainless steel reactors. Typical reactors sizes are 10,000 lts.

• The pilot plant has glass and SS vessels of 50 litres to 500 litres capacity. • Reactions can be carried out from minus 20o C to 250o C. Distillation up to 300C • Vacuum down to 1mm Hg. • Distillation systems can handle high melting solids. • High efficiency fractionating columns up to 40 theoretical plates are available. • Facilities are designed to handle a number of corrosive and hazardous raw materials.

Products:

• Tebuconazole • Hexaconazole • Propiconazole • Metalaxyl • 1,2 Pentanediol • Dicap • 4-Fluoro phenacyl chloride.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now